Hi Sarah and all,
It has been recently announced in Canada that the MS Society of Canada is funding another study by Dr. Luanne Metz of the University of Calgary and the Foothills Hospital MS Clinic. Dr. Metz did a small test of oral Minocycline in MS patients, which showed MRI improvements and then was contracted by Teva Neurosciences to do a study involving Copaxone and Minocycline. I haven't heard of any results, but they must have been promising.
The new study was announced in a recent MSSC bulletin:
A randomized, controlled trial of minocycline in Clinically Isolated Syndrome (CIS)
For many people, CIS - the first onset of an MS-like symptom - represents the earliest stage of their living with MS. Researchers believe a new teatment option for this phase might be minocycline, a well tolerated, oral, acne medication that has shown anti-inflammatory properties in animal models of MS. The study will involve 200 participants from across Canada and Dr. Luanne Metz from the University of Calgary is the lead investigator.
Notice that minocycline is called an acne medcation and not an antibiotic. Dr Metz is aware of the Vanderbilt studies and the problems that they have had with their research and told me she wouldn't go down that path.
On another note, I have stoped taking antibiotics for about five weeks now. I'll report on that in my own thread, soon.